Inter-method variability in PTH measurement: Implication for the care of CKD patients

The National Kidney Foundation/Kidney-Dialysis Outcome Quality Initiative guidelines recommend to maintain the serum intact parathyroid hormone (PTH) concentration between 150 and 300 ng/l in chronic kidney disease (CKD) stage 5 patients. As these limits were derived from studies that used the Alleg...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Kidney international 2006-07, Vol.70 (2), p.345-350
Hauptverfasser:	Souberbielle, J.-C., Boutten, A., Carlier, M.-C., Chevenne, D., Coumaros, G., Lawson-Body, E., Massart, C., Monge, M., Myara, J., Parent, X., Plouvier, E., Houillier, P.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Antibody Specificity assay standardization Chemistry, Clinical - standards chronic kidney disease Chronic Kidney Disease-Mineral and Bone Disorder - blood Chronic Kidney Disease-Mineral and Bone Disorder - diagnosis Evaluation Studies as Topic Humans immunoassay Immunoassay - standards Kidney Failure, Chronic - blood Kidney Failure, Chronic - diagnosis NKF/K-DOQI parathyroid hormone Parathyroid Hormone - analysis Parathyroid Hormone - blood Parathyroid Hormone - chemical synthesis Peptide Fragments - analysis Peptide Fragments - chemical synthesis Reference Standards Reproducibility of Results
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!